Trevi Therapeutics (TRVI) Free Cash Flow (2018 - 2026)
Trevi Therapeutics' quarterly Free Cash Flow came in at -$16.8 million in Q1 2026, down 24.59% year-on-year from -$22.3 million in Q1 2025, and down 120.04% quarter-over-quarter from -$7.6 million in Q4 2025.
Trevi Therapeutics has reported Free Cash Flow for 9 years, with the latest figure at -$16.8 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 24.59% year-over-year to -$16.8 million; the trailing twelve-month figure through Mar 2026 stood at -$45.4 million (down 10.04% YoY), and the FY2025 full-year result was -$42.1 million, down 9.95% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$16.8 million, down from -$7.6 million in the prior quarter.
- The five-year high for Free Cash Flow was -$6.2 million in Q2 2022, with the low at -$16.8 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$9.3 million, with a median of -$8.7 million recorded in 2024.
- Year-over-year, Free Cash Flow climbed 21.8% in 2022 and sank 60.54% in 2023.
- Tracing TRVI's Free Cash Flow over 5 years: stood at -$6.4 million in 2022, then grew by 1.02% to -$6.4 million in 2023, then plunged by 49.77% to -$9.6 million in 2024, then gained by 20.15% to -$7.6 million in 2025, then sank by 120.04% to -$16.8 million in 2026.
- The last three Free Cash Flow figures came in at -$16.8 million (Q1 2026), -$7.6 million (Q4 2025), and -$10.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | -16.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.79 Mn |
| Mar 31, 2026 | -16.79 Mn |
| Dec 31, 2025 | -7.63 Mn |
| Dec 31, 2025 | -7.63 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Jun 30, 2025 | -10.10 Mn |
| Jun 30, 2025 | -10.10 Mn |
| Mar 31, 2025 | -13.48 Mn |
| Mar 31, 2025 | -13.48 Mn |
| Dec 31, 2024 | -9.56 Mn |
| Dec 31, 2024 | -9.56 Mn |
| Sep 30, 2024 | -9.56 Mn |
| Sep 30, 2024 | -9.56 Mn |
| Jun 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.68 Mn |
| Mar 31, 2024 | -10.47 Mn |
| Mar 31, 2024 | -10.47 Mn |
| Dec 31, 2023 | -6.38 Mn |
| Dec 31, 2023 | -6.38 Mn |
| Sep 30, 2023 | -7.30 Mn |
| Sep 30, 2023 | -7.30 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.25 Mn |
| Mar 31, 2023 | -8.25 Mn |
| Dec 31, 2022 | -6.45 Mn |
| Dec 31, 2022 | -6.45 Mn |
| Sep 30, 2022 | -8.58 Mn |
| Sep 30, 2022 | -8.58 Mn |
| Jun 30, 2022 | -6.18 Mn |
| Jun 30, 2022 | -6.18 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Dec 31, 2021 | -6.23 Mn |
| Dec 31, 2021 | -6.23 Mn |
| Sep 30, 2021 | -7.24 Mn |
| Sep 30, 2021 | -7.24 Mn |
| Jun 30, 2021 | -7.90 Mn |
| Jun 30, 2021 | -7.90 Mn |
| Mar 31, 2021 | -7.58 Mn |
| Mar 31, 2021 | -7.58 Mn |
| Dec 31, 2020 | -8.93 Mn |
| Dec 31, 2020 | -8.93 Mn |
| Sep 30, 2020 | -6.98 Mn |
| Sep 30, 2020 | -6.98 Mn |
| Jun 30, 2020 | -8.44 Mn |
| Jun 30, 2020 | -8.44 Mn |
| Mar 31, 2020 | -4.67 Mn |
| Mar 31, 2020 | -4.67 Mn |
| Dec 31, 2019 | -6.20 Mn |
| Dec 31, 2019 | -6.20 Mn |
| Sep 30, 2019 | -7.73 Mn |
| Sep 30, 2019 | -7.73 Mn |
| Jun 30, 2019 | -5.06 Mn |
| Jun 30, 2019 | -5.06 Mn |
| Mar 31, 2019 | -4.11 Mn |
| Mar 31, 2019 | -4.11 Mn |
| Dec 31, 2018 | -4.82 Mn |
| Dec 31, 2018 | -4.82 Mn |
| Sep 30, 2018 | -3.99 Mn |
| Sep 30, 2018 | -3.99 Mn |
| Jun 30, 2018 | -5.62 Mn |
| Jun 30, 2018 | -5.62 Mn |
| Mar 31, 2018 | -4.01 Mn |
| Mar 31, 2018 | -4.01 Mn |